Allied Market Research


Cyclosporine Market

Cyclosporine Market Size, Share, Competitive Landscape and Trend Analysis Report by Type and by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Cyclosporine is an immunosuppressant medicine and natural product administered via injection and mouth into veins for the treatment of rheumatoid psoriasis, arthritis, nephrotic syndrome, Crohn's disease, and in organ transplants to prevent rejection. In addition, it is used as eye drops for dry eyes. Ciclosporin was extracted from the fungus Tolypocladium inflatum, and was eventually used for medicinal purposes.

The global cyclosporine market has witnessed significant growth, owing to its widespread use in the medical industry as an oral medicine to treat inflammation in rheumatoid arthritis and psoriasis. In addition, it is used to prevent rejection of an organ transplant, which fuels its demand, thereby supplementing the market growth. However, health concerns associated with cyclosporine such as kidney problems, high blood pressure, gum diseases tremors, and increased body hair hamper the market growth.

The global cyclosporine market is segmented based on type, application, and geography. On the basis of type, the market is bifurcated into pills and oral liquid. Applications covered in the study include hospitals and clinics. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major players operating in the global market are focusing on key market strategies such as mergers, acquisitions, collaborations, and partnerships.

Key Benefits

  • This report provides a quantitative analysis of the current trends, estimations, and dynamics¬†to assist to identify the prevailing market opportunities.
  • Major countries in each region are mapped according to the individual market revenue.
  • The region-wise and country-wise market conditions are comprehensively analyzed.
  • This study evaluates the competitive landscape and the value chain analysis to understand the competitive environment across geographies.
  • An in-depth analysis of each segment of the market is provided, to assist the prevailing market opportunities.

Cyclosporine Market Report Highlights

Aspects Details
By Type
  • Pills
  • Oral Liquid
By Application
  • Hospital
  • Clinic
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Argentina, Rest of LAMEA)
Key Market Players

Mitotech SA, Regenerx Biopharmaceuticals Inc., Otsuka Pharmaceutical, Santen Pharmaceutical Co., Ltd., Mimetogen Pharmaceuticals, Allergan, Herantis Pharma, Shire, UNITED BIOTECH (P) LTD., Alcon

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Cyclosporine Market

Global Opportunity Analysis and Industry Forecast, 2023-2032